Greenberg Traurig is a sponsor of American Conference Institute's (ACI) 19th Annual Paragraph IV Disputes conference, the premier forum which shapes the law, policy, and proceedings of Paragraph IV Litigation, in New York April 19-20. The annual conference is the only event that serves both sides of the pharmaceutical industry and offers both legal and economic takeaways for every step of this costly, complex, and evolving Paragraph IV Litigation.
Greenberg Traurig Shareholder Richard C. Pettus will be a panelist during the conference's Supreme Court update, "Amgen v. Sanofi: Understanding How the Supreme Court May Re-Shape §112." Topics discussed will include:
- Analyzing why SCOTUS granted cert only in Amgen v. Sanofi despite the presentation of the same single issue of the proper interpretation of §112 in Juno v. Kite
- Assessing the current state of 112 jurisprudence and predicting how the law may evolve in the future
- Preparing for the impact to existing patents with functional claims
- Evaluating the impact on patent prosecution practice in the future
- Best practices for strengthening or invalidating patent claims